GlassScriptPhysician profile
John Lawrence Mason
NPI 1568486884
$3,592.37
in general payments reported to CMS, 2019-2025
19 companies · $712 in 2025
The $712 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $126 · 2020: $126 · 2021: $539 · 2022: $713 · 2023: $692 · 2024: $685 · 2025: $712.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,089.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,088.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $1,471.20 | 2019-2025 | Clareon, Argos, Rocklatan |
| Abbvie INC. | $855.26 | 2022-2025 | |
| Allergan, INC. | $424.96 | 2019-2022 | |
| Oyster Point Pharma, INC. | $211.74 | 2022-2025 | Tyrvaya |
| Delcath Systems | $136.01 | 2024 | Hepzato Kit |
| Mallinckrodt Hospital Products INC. | $90.78 | 2022-2025 | Acthar |
| Bausch & Lomb Americas INC. | $80.45 | 2024-2025 | Miebo, Vyzulta |
| Apellis Pharmaceuticals, INC. | $52.69 | 2022 | |
| Tarsus Pharmaceuticals, INC. | $50.29 | 2025 | Xdemvy |
| Sun Pharmaceutical Industries INC. | $36.69 | 2022 | |
| Rxsight INC | $35.33 | 2025 | Light Adjustable Lens (Lal), Rxsight Contact Lens, Rxsight Light Delivery Device (Ldd) |
| Novartis Pharmaceuticals Corporation | $22.20 | 2023 | |
| Aerie Pharmaceuticals, INC. | $20.36 | 2021 | |
| Horizon Therapeutics Plc | $18.61 | 2023 | Tepezza |
| Carl Zeiss Meditec USA, INC. | $18.58 | 2025 | Clarus |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb, A Division of Bausch Health US, LLC | $18.50 | 2021 | |
| Sight Sciences, INC. | $17.24 | 2025 | Omni Surgical System, Sion Surgical Instrument |
| Amgen INC. | $16.58 | 2025 | Tepezza |
| Ocular Therapeutix, INC. | $14.90 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Mason listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.